Multiply Labs
PrivateLast Round
Early Funding
Mar 18, 2026
Est. Valuation
$60M
Total Funding Raised
$43.42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Multiply Labs is a biotechnology company that creates advanced robotics technology for the production of personalized pharmaceutical capsules and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Industrial Robotics, Biotech Equipment, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Multiply Labs Comparables
Compare Multiply Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellular Origins | 89% | |
| Ori Biotech | 89% | |
| Celltrio | 82% |
Multiply Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 18, 2026 | ||||
| Series A Extension | Apr 21, 2023 | ||||
| Series A | Apr 14, 2021 | ||||
| Seed | May 2, 2017 | ||||
| Accelerator | Aug 20, 2016 |
Multiply Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders Fund | Series A |
| Lux Capital | Series A |
| Garage Capital | Series A |
| Fenox Venture Capital | Seed |
| ChinaRock Capital Management | Seed |
| CRCM Ventures | Seed |
| Sorenson Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Grew 18% QoQ, from 67 to 79 employees.
- Jul 24, 2026
Monthly visitors increased 62% MoM, reaching 6.2K.
Multiply Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Multiply Labs's valuation, stock price, and market status.
Is Multiply Labs a public or private company?
Multiply Labs is a private company.
What is the current stock price of Multiply Labs?
Multiply Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Multiply Labs worth (valuation)?
Multiply Labs's valuation is estimated at $1.7M based on funding round data.
Can I buy Multiply Labs stock?
Multiply Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Multiply Labs's last funding round?
Multiply Labs's most recent funding round was Early Funding on August 1, 2016.
Who are the main investors in Multiply Labs?
Key investors in Multiply Labs include Y Combinator, Casdin Capital, P101, Mayfield Fund.
Will Multiply Labs IPO soon?
No public IPO plans have been announced for Multiply Labs.
How can I track Multiply Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Multiply Labs's secondary market activity and sign up for updates.